Virometix AG

Bronze Sponsor

Virometix AG is a privately held biotechnology company developing a new generation of fully synthetic vaccines to elicit targeted and protective immune responses against infectious diseases. Our proprietary technology, built on conformational peptide epitopes displayed on self-assembling, immunostimulatory nanoparticles, enables powerful, targeted immune responses without relying on biological materials or external adjuvants. Our vision is to set a new standard in vaccine design through innovation, precision, and synthetic excellence

website